Virally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Donofrio, Gaetano ^a   Capocefalo, Antonio ^a   Franceschi, Valentina ^a   Morini, Giorgio ^b   Del Bue, Maurizio ^a   Conti, Virna ^a   Cavirani, Sandro ^a   Grolli, Stefano ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Facolta di Medicina Veterinaria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE 3' PHOSPHOTRANSFERASE; GLYCOPROTEIN E2; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CONTROLLED STUDY; EQUINE ADIPOSE DERIVED STROMAL CELL; GENE EXPRESSION; GENETIC MANIPULATION; GENETIC TRANSFECTION; HORSE; HOUSEKEEPING GENE; NONHUMAN; PROMOTER REGION; REPORTER GENE; STROMA CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ADIPOSE TISSUE; ANIMAL; ARTHROPATHY; COMPARATIVE STUDY; CYTOLOGY; EQUINE INFECTIOUS ANEMIA VIRUS; FEASIBILITY STUDY; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; LENTIVIRUS INFECTION; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PATHOLOGY; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TRANSPLANTATION;

EQUIDAE;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, VIRAL; CELL DIFFERENTIATION; CLONING, MOLECULAR; FEASIBILITY STUDIES; GENE THERAPY; GUIDED TISSUE REGENERATION; HORSES; IMMUNITY; IMMUNIZATION; JOINT DISEASES; LENTIVIRUS INFECTIONS; LENTIVIRUSES, EQUINE; STEM CELL TRANSPLANTATION; STROMAL CELLS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 77956884599     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-73     Document Type: Article

References (23)

1. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of cellular physiology 2009, 218(2):237-245. 10.1002/jcp.21592, 18792913.
2. Koch TG, Betts DH. Stem cell therapy for joint problems using the horse as a clinically relevant animal model. Expert opinion on biological therapy 2007, 7(11):1621-1626. 10.1517/14712598.7.11.1621, 17961087.
3. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circulation research 2007, 100(9):1249-1260. 10.1161/01.RES.0000265074.83288.09, 17495232.
4. Naldini L, Verma IM. Lentiviral vectors. Advances in virus research 2000, 55:599-609. full_text, 11050959.
5. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature medicine 2001, 7(1):33-40. 10.1038/83324, 11135613.
6. Donofrio G, Sartori C, Franceschi V, Capocefalo A, Cavirani S, Taddei S, Flammini CF. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD. Vaccine 2008, 26(48):6031-6042. 10.1016/j.vaccine.2008.09.023, 18812200.
7. Donofrio G, Bottarelli E, Sandro C, Flammini CF. Expression of bovine viral diarrhea virus glycoprotein E2 as a soluble secreted form in a Mammalian cell line. Clin Vaccine Immunol 2006, 13(6):698-701. 10.1128/CVI.00071-06, 1489545, 16760329.
8. Donofrio G, Heppner FL, Polymenidou M, Musahl C, Aguzzi A. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. Journal of virology 2005, 79(13):8330-8338. 10.1128/JVI.79.13.8330-8338.2005, 1143714, 15956578.
9. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends in biotechnology 2006, 24(4):150-154. 10.1016/j.tibtech.2006.01.010, 16488036.
10. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, Gimble JM. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. Journal of cellular physiology 2006, 206(1):229-237. 10.1002/jcp.20463, 16021633.
11. Sugii S, Kida Y, Kawamura T, Suzuki J, Vassena R, Yin YQ, Lutz MK, Berggren WT, Izpisua Belmonte JC, Evans RM. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(8):3558-3563. 10.1073/pnas.0910172106, 2840462, 20133714.
12. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(37):15720-15725. 10.1073/pnas.0908450106, 2739869, 19805220.
13. Hsiao EC, Yoshinaga Y, Nguyen TD, Musone SL, Kim JE, Swinton P, Espineda I, Manalac C, deJong PJ, Conklin BR. Marking embryonic stem cells with a 2A self-cleaving peptide: a NKX2-5 emerald GFP BAC reporter. PloS one 2008, 3(7):e2532. 10.1371/journal.pone.0002532, 2430532, 18596956.
14. Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, Aebischer P, Svendsen CN. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008, 16(12):2002-2010. 10.1038/mt.2008.197, 2678899, 18797452.
15. Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PloS one 210 5(3):e9750.
16. Koch TG, Berg LC, Betts DH. Concepts for the clinical use of stem cells in equine medicine. The Canadian veterinary journal 2008, 49(10):1009-1017.
17. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of cellular physiology 2007, 213(2):341-347. 10.1002/jcp.21200, 17620285.
18. Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, Spadari A, Galli C, Lazzari G. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Veterinary research communications 2009, 33(8):811-821.
19. Donofrio G, Ravanetti L, Cavirani S, Herath S, Capocefalo A, Sheldon IM. Bacterial infection of endometrial stromal cells influences bovine herpesvirus 4 immediate early gene activation: a new insight into bacterial and viral interaction for uterine disease. Reproduction 2008, 136(3):361-366. 10.1530/REP-08-0171, 2707594, 18577555.
20. Davis SJ, Ward HA, Puklavec MJ, Willis AC, Williams AF, Barclay AN. High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. The Journal of biological chemistry 1990, 265(18):10410-10418.
21. Donofrio G, Cavirani S, Simone T, van Santen VL. Potential of bovine herpesvirus 4 as a gene delivery vector. J Virol Methods 2002, 101(1-2):49-61. 10.1016/S0166-0934(01)00419-0, 11849683.
22. Mettenleiter TC. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 1989, 171(2):623-625. 10.1016/0042-6822(89)90635-1, 2548334.
23. Santoni de Sio F, Naldini L. Short-term culture of human CD34+ cells for lentiviral gene transfer. Methods in molecular biology (Clifton, NJ) 2009, 506:59-70.